Cardiac Dimensions has secured $53m in a Series E funding round to support its ongoing pivotal trial assessing the company’s ...

Doctors at Duke Health have successfully performed the world’s first living mitral valve replacement, saving three lives in North Carolina.

Growing investments in healthcare infrastructure and advancements in medical research facilities are driving the expansion of ...

Laplace Interventional, a US-based medical device company focusing on transcatheter valve technology, recently announced the ...

Out-of-hospital mortality before 30 days was 1.2%, with roughly two-thirds of these patients dying from cardiovascular causes ...

Kirkland-based heart care company Cardiac Dimensions on Thursday raised a $53 million Series E round.

Partial heart transplants provide a range of lifesaving options for children with complex congenital heart conditions, and ...

Rising prevalence of cardiovascular diseases and rapid advancements in minimally invasive procedures are fueling the growth ...

Dr Rajneesh Kapoor highlights the evolution of structural heart disease treatments, exploring the impact of transcatheter ...

Many patients with atrial functional mitral regurgitation are not suitable candidates for surgery or transcatheter repair. For transcatheter mitral valve replacement, a common contraindication is the ...